首页 > 最新文献

Progresos en Obstetricia y Ginecologia最新文献

英文 中文
Linfoma mamario tipo MALT asociado a virus de hepatitis C: exposición de dos casos y revisión de la literatura
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/J.POG.00103
R. Herrera, E. Gómez, JJ Gil-Fernández, P. R. Guillén, L. Zaragoza
espanolObjetivos: los linfomas no Hodgkin primarios de mama son una entidad confundible con el carcinoma de mama, por lo que es importante el diagnostico diferencial. Presentamos 2 casos de linfoma mamario diagnosticados en nuestro centro junto con una revision bibliografica. Resultados: el linfoma de mama no presenta sintomas ni signos especificos y su diagnostico es histologico. El tratamiento consiste en radioquimioterapia y farmacos biologicos. En asociacion con VHC, el tratamiento de dicho virus sera la base para el tratamiento del linfoma. Conclusion: el estudio del linfoma primario de mama es necesario para realizar un buen diagnostico, asi como para proporcionar a nuestras pacientes el tratamiento correcto. EnglishObjetives: Primary breast lymphoma is a disease that can be mistaken for breast carcinoma, so is important a knowledge about it in order to do a differential diagnosis. We present 2 cases of primary breast lymphoma diagnosed in our center, with a review of the literature. Results: Primary breast lymphoma don´t present specific clinical findings, so diagnosis is histopatological. Treatment proposed is a combination of radio-chemotherapy and biological drugs. In association between primary breast lymphoma and HCV, treatment of HCV will be also primary breast lymphoma treatment. Conclusion: The study of primary breast lymphoma is necessary in order to do a correct diagnostic, and consequently give a good treatment.
目的:原发性非霍奇金淋巴瘤是一种与乳腺癌混淆的实体,因此鉴别诊断很重要。我们提出了2例在我们中心诊断的乳腺淋巴瘤病例,并进行了文献综述。结果:乳腺癌无特异性症状和体征,组织学诊断。治疗包括放疗和生物药物。与hcv联合治疗,这种病毒的治疗将成为淋巴瘤治疗的基础。结论:原发性乳腺淋巴瘤的研究对于良好的诊断和为患者提供正确的治疗是必要的。原发性乳腺淋巴瘤是一种可能被错误地诊断为乳腺癌的疾病,因此了解它对区分诊断很重要。我们目前2 cases of primary乳房lymphoma所指in our中心,with a review of the文献。结果:原发性乳腺淋巴瘤没有具体的临床发现,因此诊断为组织病理学。= =地理= =根据美国人口普查,这个县的面积为。= =地理= =根据美国人口普查,这个县的面积为,其中土地和(1.2%)水。结论:原发性乳腺淋巴瘤的研究对于正确诊断和治疗是必要的。
{"title":"Linfoma mamario tipo MALT asociado a virus de hepatitis C: exposición de dos casos y revisión de la literatura","authors":"R. Herrera, E. Gómez, JJ Gil-Fernández, P. R. Guillén, L. Zaragoza","doi":"10.20960/J.POG.00103","DOIUrl":"https://doi.org/10.20960/J.POG.00103","url":null,"abstract":"espanolObjetivos: los linfomas no Hodgkin primarios de mama son una entidad confundible con el carcinoma de mama, por lo que es importante el diagnostico diferencial. Presentamos 2 casos de linfoma mamario diagnosticados en nuestro centro junto con una revision bibliografica. Resultados: el linfoma de mama no presenta sintomas ni signos especificos y su diagnostico es histologico. El tratamiento consiste en radioquimioterapia y farmacos biologicos. En asociacion con VHC, el tratamiento de dicho virus sera la base para el tratamiento del linfoma. Conclusion: el estudio del linfoma primario de mama es necesario para realizar un buen diagnostico, asi como para proporcionar a nuestras pacientes el tratamiento correcto. EnglishObjetives: Primary breast lymphoma is a disease that can be mistaken for breast carcinoma, so is important a knowledge about it in order to do a differential diagnosis. We present 2 cases of primary breast lymphoma diagnosed in our center, with a review of the literature. Results: Primary breast lymphoma don´t present specific clinical findings, so diagnosis is histopatological. Treatment proposed is a combination of radio-chemotherapy and biological drugs. In association between primary breast lymphoma and HCV, treatment of HCV will be also primary breast lymphoma treatment. Conclusion: The study of primary breast lymphoma is necessary in order to do a correct diagnostic, and consequently give a good treatment.","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80580794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Encuesta SEGO. Predicción, diagnóstico y tratamiento de la preeclampsia en los hospitales españoles SEGO调查。西班牙医院子痫前期的预测、诊断和治疗
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/j.pog.00067
I HerraizGarcía, M PertegalRuiz, Delgado Marí Jl, A. GalindoIzquierdo
espanolObjetivos: la preeclampsia es causa importante de morbilidad y mortalidad materna y perinatal. La identificacion de gestantes con riesgo de preeclampsia, el correcto diagnostico y la adecuada evaluacion del pronostico son fundamentales para la eleccion de la actitud clinica mas adecuada en cada caso y lograr evitar asi las complicaciones asociadas y la mortalidad por preeclampsia. En este sentido, en los ultimos anos se han desarrollado y estudiado numerosos biomarcadores que, bien por si mismos o en combinacion con otros parametros, muestran resultados prometedores en la prediccion y diagnostico de preeclampsia, y cuya incorporacion a la practica clinica habitual supondra un avance en el manejo clinico de las gestantes con preeclampsia. Material y metodos: desde la Sociedad Espanola de Ginecologia y Obstetricia se envio via internet una encuesta con 25 preguntas (3 de ellas casos clinicos) a 2.699 miembros de la secciones de Medicina Perinatal y Ecografia con el objetivo de revisar el estado actual de la prediccion, diagnostico y manejo clinico de la preeclampsia en nuestro pais. Resultados: a la encuesta respondieron 476 profesionales (17,63%) y de sus respuestas se concluye que la practica clinica entre los profesionales de los hospitales espanoles se ajusta en la mayoria de los aspectos evaluados a las recomendaciones actuales y al estado del conocimiento. Cabe destacar la baja utilizacion de biomarcadores en el primer trimestre para identificar gestantes con riesgo de preeclampsia e indicar profilaxis asi como en el segundo y tercer trimestre para establecer el pronostico y optimizar la actitud terapeutica. EnglishObjectives: Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. The correct diagnosis, prognosis, and identification of patients at high risk of pre-eclampsia are crucial for the optimal treatment and prevention of pre-eclampsia-associated complications and mortality. A large variety of prognostic and diagnostic biomarkers have been studied in the recent years either alone or in combination with other parameters, with promising results. The routine use of these biomarkers in clinical practice would help optimize the clinical approach to pre-eclampsia. Material and methods: The Spanish Society of Gynecology and Obstetrics forwarded an online 25-item questionnaire (of which 3 were clinical cases) to 2.699 members of the departments of perinatal medicine and ultrasound with the aim of revising how pre-eclampsia is predicted, diagnosed, and treated in Spain. Results: A total of 476 questionnaires (17.63%) were returned. The conclusion was that most aspects addressed in the questionnaire were approached in hospitals in Spain in accordance with official guidelines and the current state of knowledge. Of note is the rare use of biomarkers either during the first trimester of gestation in patients at risk of pre-eclampsia for the indication of prophylaxis, or during the second and third trimester for t
西班牙:子痫前期是孕产妇和围产期发病和死亡的主要原因。在这种情况下,有子痫前期风险的孕妇的识别、正确的诊断和适当的预后评估是在每个病例中选择最合适的临床态度的基础,从而避免相关的并发症和子痫前期死亡率。在此意义上,这些年来在发展和研究的许多生物标记,好你自己或与其他parametros组合,结果显示在prediccion diagnostico前兆和其incorporacion标准实施手术supondra进步与孕妇妊娠高血压临床管理。和metodos材料:从西班牙语的妇产科和Ginecologia社会网站的一项调查,与部属25问题(其中3例clinicos 2.699成员)围产期医学和Ecografia节,目的是审查现状prediccion, diagnostico和临床妊娠高血压管理在我们的国家。结果:476名专业人员(17.63%)参与了调查,从他们的回答中得出结论,西班牙医院专业人员的临床实践在大多数评估方面符合当前的建议和知识状态。值得注意的是,在前三个月使用生物标志物来识别有子痫前期风险的孕妇并指示预防措施,以及在中、晚期建立预后和优化治疗态度。子痫前期是孕产妇和围产期发病率和死亡率的主要原因。正确诊断、预后和识别子痫前期高危患者对于最佳治疗和预防子痫前期相关并发症和死亡率至关重要。近年来,人们对各种各样的预后和诊断生物标志物进行了研究,无论是单独研究还是与其他参数结合研究,结果都很有希望。在临床实践中常规使用这些生物标记物将有助于改进子宫颈前的临床方法。材料和方法:西班牙妇产科学会向2 699名围产期医学和超声科成员发送了一份在线25项问卷(其中3例为临床病例),目的是审查西班牙如何预测、诊断和治疗子痫前期。结果:共退回476份问卷(17.63%)。结论是,调查表所涉及的大多数方面都是西班牙医院按照官方准则和目前的知识状况处理的。值得注意的是,在妊娠的前三个月,有子痫前期风险的患者很少使用生物标志物作为预防适应症,或者在妊娠的第二和第三个月,用于预后和选择最佳治疗方案。
{"title":"Encuesta SEGO. Predicción, diagnóstico y tratamiento de la preeclampsia en los hospitales españoles","authors":"I HerraizGarcía, M PertegalRuiz, Delgado Marí Jl, A. GalindoIzquierdo","doi":"10.20960/j.pog.00067","DOIUrl":"https://doi.org/10.20960/j.pog.00067","url":null,"abstract":"espanolObjetivos: la preeclampsia es causa importante de morbilidad y mortalidad materna y perinatal. La identificacion de gestantes con riesgo de preeclampsia, el correcto diagnostico y la adecuada evaluacion del pronostico son fundamentales para la eleccion de la actitud clinica mas adecuada en cada caso y lograr evitar asi las complicaciones asociadas y la mortalidad por preeclampsia. En este sentido, en los ultimos anos se han desarrollado y estudiado numerosos biomarcadores que, bien por si mismos o en combinacion con otros parametros, muestran resultados prometedores en la prediccion y diagnostico de preeclampsia, y cuya incorporacion a la practica clinica habitual supondra un avance en el manejo clinico de las gestantes con preeclampsia. Material y metodos: desde la Sociedad Espanola de Ginecologia y Obstetricia se envio via internet una encuesta con 25 preguntas (3 de ellas casos clinicos) a 2.699 miembros de la secciones de Medicina Perinatal y Ecografia con el objetivo de revisar el estado actual de la prediccion, diagnostico y manejo clinico de la preeclampsia en nuestro pais. Resultados: a la encuesta respondieron 476 profesionales (17,63%) y de sus respuestas se concluye que la practica clinica entre los profesionales de los hospitales espanoles se ajusta en la mayoria de los aspectos evaluados a las recomendaciones actuales y al estado del conocimiento. Cabe destacar la baja utilizacion de biomarcadores en el primer trimestre para identificar gestantes con riesgo de preeclampsia e indicar profilaxis asi como en el segundo y tercer trimestre para establecer el pronostico y optimizar la actitud terapeutica. EnglishObjectives: Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. The correct diagnosis, prognosis, and identification of patients at high risk of pre-eclampsia are crucial for the optimal treatment and prevention of pre-eclampsia-associated complications and mortality. A large variety of prognostic and diagnostic biomarkers have been studied in the recent years either alone or in combination with other parameters, with promising results. The routine use of these biomarkers in clinical practice would help optimize the clinical approach to pre-eclampsia. Material and methods: The Spanish Society of Gynecology and Obstetrics forwarded an online 25-item questionnaire (of which 3 were clinical cases) to 2.699 members of the departments of perinatal medicine and ultrasound with the aim of revising how pre-eclampsia is predicted, diagnosed, and treated in Spain. Results: A total of 476 questionnaires (17.63%) were returned. The conclusion was that most aspects addressed in the questionnaire were approached in hospitals in Spain in accordance with official guidelines and the current state of knowledge. Of note is the rare use of biomarkers either during the first trimester of gestation in patients at risk of pre-eclampsia for the indication of prophylaxis, or during the second and third trimester for t","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76724956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fascitis necrotizante en cicatriz de cesárea. Revisión de la literatura 剖宫产瘢痕中的坏死性筋膜炎。本研究的目的是:
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/j.pog.00104
M. Pantoja Garrido, Z. Frías Sánchez, F.J. Pantoja Rosso, F.J. Vico de Miguel
{"title":"Fascitis necrotizante en cicatriz de cesárea. Revisión de la literatura","authors":"M. Pantoja Garrido, Z. Frías Sánchez, F.J. Pantoja Rosso, F.J. Vico de Miguel","doi":"10.20960/j.pog.00104","DOIUrl":"https://doi.org/10.20960/j.pog.00104","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72946904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteína C reactiva y doppler de arterias uterinas en preeclámpticas
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/J.POG.00064
E. Reyna-Villasmil,, Jorly Mejía-Montilla, Martha Rondón-Tapia, Joel Santos-Bolívar, D. Torres-Cepeda, Yolimar Navarro-Briceño, Nadia Reyna-Villasmil
espanolObjetivo: establecer las concentraciones plasmaticas de proteina C reactiva en preeclampticas y embarazadas normotensas y relacionar los valores de los parametros de velocimetria doppler de las arterias uterinas con las concentraciones sericas. Material y metodos: se seleccionaron 160 mujeres. Se incluyeron 80 preeclampticas como los casos (grupo A) y un grupo control que fue seleccionado por tener una edad y un indice de masa corporal similares al grupo de estudio de 80 embarazadas sanas (grupo B). Las muestras de sangre para la determinacion de proteina C reactiva y las mediciones de los indices de pulsatilidad, indice de resistencia y relacion de flujo sistolico/diastolico de las arterias uterinas se realizaron en todas las pacientes antes del parto e inmediatamente despues del diagnostico en el grupo de casos. Resultados: las pacientes del grupo A presentaron concentraciones significativamente mas elevadas de proteina C reactiva que las embarazadas del grupo B (p Conclusiones: las preeclampticas presentan concentraciones plasmaticas de proteina C reactiva mas altas que las embarazadas normotensas y existe correlacion significativa entre las concentraciones plasmaticas y los parametros de velocimetria doppler de las arterias uterinas. EnglishObjective: To establish plasma C-reactive protein concentrations in patients with preeclampsia and healthy normotensive pregnant women and to relate Doppler velocimetry to serum concentrations. Material and methods: One hundred sixty patients were selected. Eighty preeclamptic patients were selected as cases (group A) and 80 healthy pregnant women with a similar age and body mass index to patients in group A were selected as controls (group B). Blood samples for C-reactive protein and measurements of pulsatility index, resistance index and systolic/diastolic blood flow ratio of uterine arteries were done in all patients before labor and immediately after diagnosis in the study group. Results: There was found significant differences were found in C-reactive protein concentrations in the group A and patients in group B (p Conclusions: Preeclamptic patients showed higher plasma C-reactive protein concentration than normotensive pregnant women and there is a significant correlation between plasma concentrations and parameters of Doppler velocimetry of uterine arteries.
目的:建立子痫前期和血压正常孕妇血浆C反应蛋白浓度,并将子宫动脉多普勒测速参数值与血清浓度联系起来。和metodos材料:选取了160名。包括80 preeclampticas作为病例组(A组)和对照组当选有一个年龄和体重指数类似学习小组80健康孕妇组(B组),血样用于determinacion蛋白激酶C反应和测量pulsatilidad索引条目,所有患者在分娩前和诊断后立即进行子宫动脉阻力指数和舒张/收缩流量关系。结果:女性患者集团介绍C反应蛋白含量显著更高,B组的孕妇(p的结论:各种preeclampticas plasmaticas C反应蛋白浓度最高,孕妇normotensas浓度之间存在显著correlacion plasmaticas和velocimetria parametros多普勒distress动脉。目的:建立子痫前期和健康血压正常孕妇血浆c反应蛋白浓度,并将多普勒测速与血清浓度联系起来。材料与方法:选取160例患者。美国preeclamptic patients是选定的案件(group)和80健康孕妇women with A age and body)的类似大众index to patients in group A被选定作为管制(group B)。血液samples for C-reactive protein measurements of pulsatility index, resistance index and systolic / diastolic血液flow比例of uterine》被立即捐in之前的所有patients labour and after诊断in the study group。结果:There was found开展差异是found in C-reactive protein检测in the group A and patients in group B (p的结论:Preeclamptic patients等离子显示higher C-reactive protein多元化than normotensive贫血和法律是否correlation between等离子体检测和勒velocimetry parameters uterine》。
{"title":"Proteína C reactiva y doppler de arterias uterinas en preeclámpticas","authors":"E. Reyna-Villasmil,, Jorly Mejía-Montilla, Martha Rondón-Tapia, Joel Santos-Bolívar, D. Torres-Cepeda, Yolimar Navarro-Briceño, Nadia Reyna-Villasmil","doi":"10.20960/J.POG.00064","DOIUrl":"https://doi.org/10.20960/J.POG.00064","url":null,"abstract":"espanolObjetivo: establecer las concentraciones plasmaticas de proteina C reactiva en preeclampticas y embarazadas normotensas y relacionar los valores de los parametros de velocimetria doppler de las arterias uterinas con las concentraciones sericas. Material y metodos: se seleccionaron 160 mujeres. Se incluyeron 80 preeclampticas como los casos (grupo A) y un grupo control que fue seleccionado por tener una edad y un indice de masa corporal similares al grupo de estudio de 80 embarazadas sanas (grupo B). Las muestras de sangre para la determinacion de proteina C reactiva y las mediciones de los indices de pulsatilidad, indice de resistencia y relacion de flujo sistolico/diastolico de las arterias uterinas se realizaron en todas las pacientes antes del parto e inmediatamente despues del diagnostico en el grupo de casos. Resultados: las pacientes del grupo A presentaron concentraciones significativamente mas elevadas de proteina C reactiva que las embarazadas del grupo B (p Conclusiones: las preeclampticas presentan concentraciones plasmaticas de proteina C reactiva mas altas que las embarazadas normotensas y existe correlacion significativa entre las concentraciones plasmaticas y los parametros de velocimetria doppler de las arterias uterinas. EnglishObjective: To establish plasma C-reactive protein concentrations in patients with preeclampsia and healthy normotensive pregnant women and to relate Doppler velocimetry to serum concentrations. Material and methods: One hundred sixty patients were selected. Eighty preeclamptic patients were selected as cases (group A) and 80 healthy pregnant women with a similar age and body mass index to patients in group A were selected as controls (group B). Blood samples for C-reactive protein and measurements of pulsatility index, resistance index and systolic/diastolic blood flow ratio of uterine arteries were done in all patients before labor and immediately after diagnosis in the study group. Results: There was found significant differences were found in C-reactive protein concentrations in the group A and patients in group B (p Conclusions: Preeclamptic patients showed higher plasma C-reactive protein concentration than normotensive pregnant women and there is a significant correlation between plasma concentrations and parameters of Doppler velocimetry of uterine arteries.","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72751018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seguimiento de las recomendaciones SEGO sobre el Sangrado Menstrual Abundante (Estudio SMA-UR) 随访SEGO关于月经大出血的建议(SMA-UR研究)
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/j.pog.00075
M. J. Hidalgo, Mercedes Andeyro García, J. C. Alsina, Josep Estadella Tarriel, J. Conde, N. Guevara, M. C. Rancel, A. C. Sánchez, Ignasi Canals
{"title":"Seguimiento de las recomendaciones SEGO sobre el Sangrado Menstrual Abundante (Estudio SMA-UR)","authors":"M. J. Hidalgo, Mercedes Andeyro García, J. C. Alsina, Josep Estadella Tarriel, J. Conde, N. Guevara, M. C. Rancel, A. C. Sánchez, Ignasi Canals","doi":"10.20960/j.pog.00075","DOIUrl":"https://doi.org/10.20960/j.pog.00075","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76812178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hernia y embarazo: diagnóstico y manejo terapéutico 疝气与怀孕:诊断与治疗管理
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/J.POG.00093
B. Guerrero, J. Carro, M. Pascual, A. García
{"title":"Hernia y embarazo: diagnóstico y manejo terapéutico","authors":"B. Guerrero, J. Carro, M. Pascual, A. García","doi":"10.20960/J.POG.00093","DOIUrl":"https://doi.org/10.20960/J.POG.00093","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81506670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Síndrome miasténico congénito en gestante: entidad clínica poco frecuente 孕妇先天性肌腱综合征:罕见的临床实体
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/j.pog.00072
Nuria Castelló Martínez, Mónica de Vera Gomis, Joaquín Rodríguez Pérez, Ernesto Bas Esteve, Carmen Díaz-Caneja Planell
{"title":"Síndrome miasténico congénito en gestante: entidad clínica poco frecuente","authors":"Nuria Castelló Martínez, Mónica de Vera Gomis, Joaquín Rodríguez Pérez, Ernesto Bas Esteve, Carmen Díaz-Caneja Planell","doi":"10.20960/j.pog.00072","DOIUrl":"https://doi.org/10.20960/j.pog.00072","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78999568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF 利用sFlt-1/PlGF比值更新单次妊娠子痫前期的诊断和预后
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/J.POG.00061
Ignacio Herraiz García, Elisa Llurba Olivé, A. Izquierdo, Stefan Verlohren
{"title":"Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF","authors":"Ignacio Herraiz García, Elisa Llurba Olivé, A. Izquierdo, Stefan Verlohren","doi":"10.20960/J.POG.00061","DOIUrl":"https://doi.org/10.20960/J.POG.00061","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84205548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Situación actual de la preeclampsia 子痫前期的现状
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/j.pog.00039
Departamento Editorial Arán
{"title":"Situación actual de la preeclampsia","authors":"Departamento Editorial Arán","doi":"10.20960/j.pog.00039","DOIUrl":"https://doi.org/10.20960/j.pog.00039","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81836258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El ejercicio físico durante el embarazo y su influencia en la ganancia de peso materno 怀孕期间的体育锻炼及其对母亲体重增加的影响
Q4 Medicine Pub Date : 2019-01-01 DOI: 10.20960/J.POG.00105
R. Barakat, R. Bernabé, Evelia Franco, T. P. Medina
{"title":"El ejercicio físico durante el embarazo y su influencia en la ganancia de peso materno","authors":"R. Barakat, R. Bernabé, Evelia Franco, T. P. Medina","doi":"10.20960/J.POG.00105","DOIUrl":"https://doi.org/10.20960/J.POG.00105","url":null,"abstract":"","PeriodicalId":35677,"journal":{"name":"Progresos en Obstetricia y Ginecologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79162116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Progresos en Obstetricia y Ginecologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1